25 Oct 2025

Avacta presents first preclinical data from dual payload pre|CISION^® medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

Investors | Therapeutics

23 Oct 2025

Notice of Investor Presentation

Investors

20 Oct 2025

Equity fundraise of £16 million

Investors

13 Oct 2025

Research & Development Spotlight Series, Episode 12

Investors | R&D Spotlights Series | Therapeutics

30 Sep 2025

Interim Results for the six months to June 30, 2025

Investors | Therapeutics

15 Sep 2025

Notice of Interim Results and Investor Presentation

Investors | Therapeutics

09 Sep 2025

Avacta’s pre|CISION^® Platform Shortlisted for the Technology of the Year Award at the AIM Awards

Investors | Therapeutics

01 Sep 2025

Avacta Announces Completion of the Sale of Coris Bioconcept SRL

Diagnostics | Investors

29 Aug 2025

Amendments to the Convertible Bond and equity fundraise of £3.25 million

Investors | Therapeutics

28 Jul 2025

Avacta Announces Agreement to Sell Coris Bioconcept SRL

Diagnostics | Investors